Microbiological Efficacy of Levofloxacin for Treatment of Community-Acquired Pneumonia Due to Chlamydia pneumoniae

Gelijkaardige items

• Microbiologic Efficacy of Azithromycin and Susceptibilities to Azithromycin of Isolates of Chlamydia pneumoniae from Adults and Children with Community-Acquired Pneumonia
  door: Roblin, Patricia M., et al.
  Gepubliceerd in: (1998)
• Effect of Prolonged Treatment with Azithromycin, Clarithromycin, or Levofloxacin on Chlamydia pneumoniae in a Continuous-Infection Model
  door: Kutlin, Andrei, et al.
  Gepubliceerd in: (2002)
• Community-acquired Chlamydia pneumoniae pneumonia.
  door: Falguera, M., et al.
  Gepubliceerd in: (1996)
• Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
  door: Tanaseanu, Cristina, et al.
  Gepubliceerd in: (2009)
• Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia
  door: van Rensburg, Dirkie J. J., et al.
  Gepubliceerd in: (2010)